First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the recipient of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 19,031 shares, a decrease of 85.8% from the August 31st total of 134,463 shares. Based on an average daily trading volume, of 35,950 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.1% of the company’s stock are short sold.

Hedge Funds Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Hedge funds have recently bought and sold shares of the business. Compass Financial Management LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter valued at about $29,000. Flputnam Investment Management Co. purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at approximately $230,000. Vivaldi Capital Management LP raised its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after purchasing an additional 1,741 shares during the last quarter. Finally, Nilsine Partners LLC lifted its position in First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock valued at $1,071,000 after purchasing an additional 937 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 0.6%

FTXH stock traded down $0.24 during midday trading on Friday, hitting $41.33. The company’s stock had a trading volume of 5,867 shares, compared to its average volume of 214,261. The firm’s 50-day moving average is $40.51 and its 200-day moving average is $37.03. First Trust Nasdaq Pharmaceuticals ETF has a 12 month low of $27.40 and a 12 month high of $42.87. The company has a market cap of $1.19 billion, a PE ratio of 14.51 and a beta of 0.46.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Thursday, September 24th will be given a dividend of $0.0113 per share. This represents a $0.05 annualized dividend and a dividend yield of 0.1%. This is a drop from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. The ex-dividend date of this dividend is Thursday, September 24th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.